Triglyceride-lowering effect of pitvastatin in a rat model of postprandial lipemia

European Journal of Pharmacology

Volumn 444, Issue 1-2, 2002, Pages 107-113

  Aoki, Taro ^a   Yoshinaka, Yasunobu ^a   Yamazaki, Hiroyuki ^a   Suzuki, Hideo ^a   Tamaki, Taro ^a   Sato, Fumiyasu ^a   Kitahara, Masaki ^b   Saito, Yasushi ^c  

^a KOWA COMPANY LTD   (Japan)

^b NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3 Hydroxy 3 methylglutaryl coenzyme A reductase inhibitor; Lymph chylomicron; Microsomal triglyceride transfer protein; Model of postprandial lipemia; Pitavastatin

Indexed keywords

ATORVASTATIN; CHYLOMICRON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PITAVASTATIN; TRIACYLGLYCEROL; QUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID TRANSPORT; LYMPH; MALE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; WISTAR RAT;

ANIMAL; CHYLOMICRONS; HYPERLIPIDEMIA; MALE; POSTPRANDIAL PERIOD; QUINOLINES; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES; ANIMALS; HYPERLIPIDEMIAS;

EID: 0037165840     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01547-9     Document Type: Article

References (30)

1. Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carnitine acyltransferases
2. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
3. Postprandial apolipoprotein B48- and B100-containing lipoproteins in type 2 diabetes: Do statins have a specific effect on triglyceride metabolism?
4. The HMG-CoA reductase inhibitor atorvastatin increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs
5. Relationship between dietary intake and coronary heart disease mortality: Lipid research clinics prevalence follow-up study
6. The quantitative separation of chylomicrons and chylomicron remnants by column chromatography
7. Studies on the metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase (4): Interspecies variation in laboratory animals and humans
8. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats
9. ATP binding and hydrolysis by the multifunctional protein disulfide isomerase
10. A proposed model for the assembly of chylomicrons
11. The ER translocon and retrotranslocation: Is the shift into reverse manual or automatic?
12. Effects of pitavastatin, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia
13. Studies on the metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase (1): Absorption, distribution, metabolism and excretion in rats
14. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: Triglyceride-lowering in rats correlates with efficacy in LDL animal models
15. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: Insulin negatively regulate MTP gene expression
16. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
17. Current perspectives on statins
18. Increased proliferative response of lymphocytes from intestinal lymph during long chain fatty acid absorption
19. Pharmacokinetic studies on CI-981 (1): Absorption, distribution and excretion in rats following single oral or intravenous administration
20. The assembly and secretion of apolipoprotein B-containing lipoproteins
21. Effects of drugs on postprandial lipoprotein metabolism
22. A major phosphoprotein of the endoplasmic reticulum is protein disulfide isomerase
23. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription
24. Endoplasmic reticulum degradation: Reverse protein flow of no return
25. Hypolipidemic effect of pitavastatin, a potent HMG-CoA reductase inhibitor, in guinea pigs
26. The activity of microsomal triglyceride transfer protein is essential for accumulation of triglyceride within microsomes in McA-RH7777 cells. A unified model for the assembly of very low density lipoproteins
27. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: Case control study over three years
28. Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues
29. Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein
30. Atherogenesis: A postprandial phenomenon